7 participants
Study With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Peritoneal Malignancies
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-10-19
- Start Date:
- 2018-06-18
- Completion:
- 2021-05-30
Conditions
- Peritoneal Malignancies
Interventions
- DRUG
No Results Yet